TScan Therapeutics, Inc. - Common Stock (NQ:TCRX)

0.2851 -0.0354 (-11.05%)

Delayed Quote Updated: 1:43 PM EDT, Oct 5, 2026 Add to My Watchlist

Quote

Overview Detailed Quote Charting Historical Prices

News

All News News Headlines Press Releases

Research

Quarterly Reports Insider Filings Other Filings

All News about TScan Therapeutics, Inc. - Common Stock

< Previous 1 2 3 4 5 6 7 Next >

TScan Therapeutics Announces Presentation at the H.C. Wainwright Cell Therapy Virtual Conference

February 21, 2023

From TScan Therapeutics, Inc.

Via GlobeNewswire

12 Health Care Stocks Moving In Wednesday's After-Market Session ↗

January 25, 2023

Via Benzinga

Today’s Biggest Pre-Market Stock Movers: 10 Top Gainers and Losers on Tuesday ↗

January 24, 2023

We're starting the day with a look at the biggest pre-market stock movers traders need to know about on Tuesday morning!

Via InvestorPlace

TScan Therapeutics Announces FDA Clearance of Three Investigational New Drug Applications for the Treatment of Solid Tumors

January 23, 2023

From TScan Therapeutics, Inc.

Via GlobeNewswire

TScan Therapeutics Announces 2023 Clinical Plans and Highlights Recent Progress

January 05, 2023

From TScan Therapeutics, Inc.

Via GlobeNewswire

TScan Therapeutics Presents Phase 1 Umbrella Trial in Progress on HA-1 (TSC-100) and HA-2 (TSC-101) at the 64th American Society of Hematology Annual Meeting 2022

December 12, 2022

Poster presents Phase 1 trial design and translational assays to generate early evidence of biological activity in residual leukemia after hematopoietic cell transplantation

From TScan Therapeutics, Inc.

Via GlobeNewswire

TScan Therapeutics Named the Highest-Placed Midsize Biotechnology Company in The Top Places to Work for 2022 by The Boston Globe

December 01, 2022

From TScan Therapeutics, Inc.

Via GlobeNewswire

TScan Therapeutics to Participate in the 5th Annual Evercore ISI HealthCONx Conference

November 22, 2022

From TScan Therapeutics, Inc.

Via GlobeNewswire

TScan Therapeutics Presents Preclinical Data for Solid Tumor Program at the 37th Society for Immunotherapy of Cancer Annual Meeting

November 11, 2022

From TScan Therapeutics, Inc.

Via GlobeNewswire

TScan Therapeutics Reports Third Quarter 2022 Financial Results and Provides Business Update

November 09, 2022

From TScan Therapeutics, Inc.

Via GlobeNewswire

TScan Therapeutics Announces Upcoming Virtual Investor Event

November 07, 2022

From TScan Therapeutics, Inc.

Via GlobeNewswire

TScan Therapeutics Announces Upcoming Poster Presentation at the 64th American Society of Hematology Annual Meeting and Exposition

November 03, 2022

From TScan Therapeutics, Inc.

Via GlobeNewswire

TScan Therapeutics Announces Upcoming Poster Presentations at the 37th Society for Immunotherapy of Cancer Annual Meeting

October 05, 2022

From TScan Therapeutics, Inc.

Via GlobeNewswire

Why Lululemon Athletica Is Trading Higher By 11%, Here Are 36 Stocks Moving In Friday's Mid-Day Session ↗

September 02, 2022

Gainers

Via Benzinga

Why HyreCar Is Trading Higher By 60%, Here Are 63 Stocks Moving In Tuesday's Mid-Day Session ↗

September 06, 2022

Gainers HyreCar Inc. (NASDAQ: HYRE) jumped 60% to $1.2680 after the company announced it has received a $100 million revolving line of credit from a premier global investment bank and Medalist...

Via Benzinga

40 Stocks Moving In Wednesday's Mid-Day Session ↗

June 22, 2022

Gainers Ocean Bio-Chem, Inc. (NASDAQ: OBCI) shares jumped 116.6% to $12.82 after the company announced it will be acquired by OneWater Marine for $13.08 per share in cash.

Via Benzinga

Why PolyPid Dipped Over 73%; Here Are 60 Biggest Movers From Friday ↗

September 06, 2022

Gainers Venus Concept Inc. (NASDAQ: VERO) jumped 54.9% to settle at $0.5419 on Friday. The company, last month, posted downbeat quarterly results.

Via Benzinga

12 Health Care Stocks Moving In Thursday's Intraday Session ↗

May 19, 2022

Via Benzinga

76 Biggest Movers From Yesterday: Ocean Bio-Chem, Athira Pharma And More ↗

June 23, 2022

Gainers Ocean Bio-Chem, Inc. (NASDAQ: OBCI) shares climbed 117.2% to close at $12.86 on Wednesday after the company announced it will be acquired by OneWater Marine for $13.08 per share in cash.

Via Benzinga

12 Health Care Stocks Moving In Thursday's After-Market Session ↗

May 12, 2022

Gainers

Via Benzinga

71 Biggest Movers From Yesterday ↗

May 20, 2022

Gainers NeuroMetrix, Inc. (NASDAQ: NURO) shares jumped 76.3% to close at $5.50 on Thursday after the company announced the FDA has granted De Novo authorization to market the Quell neuromodulation...

Via Benzinga

The Daily Biotech Pulse: Pfizer Begins Late-Stage Pediatric COVID Pill Study, Midatech And J&J Unit Expand R&D Collaboration, AbbVie-Alvotech Settle Humira Dispute ↗

March 09, 2022

Here's a roundup of top developments in the biotech space over the last 24 hours. Stocks In Focus AbbVie Settles With Alvotech On Humira Biosimilar Patent Dispute AbbVie, Inc...

Via Benzinga

110 Biggest Movers From Friday ↗

May 16, 2022

Gainers ShiftPixy, Inc. (NASDAQ: PIXY) shares jumped 154.9% to close at $0.51. ShiftPixy reported board approval special dividend to shareholders in form of common shares of Industrial Human Capital.

Via Benzinga

56 Stocks Moving In Friday's Mid-Day Session ↗

May 13, 2022

Gainers Veru Inc. (NASDAQ: VERU) shares jumped 62.5% to $14.67 after the company reported quarterly results on Thursday. Jefferies maintained Veru with a Buy and raised the price target from $33 to...

Via Benzinga

FDA Gives Nod To TScan Therapeutics' Early-Stage Trial Of TSC-100 In Hematologic Malignancies ↗

January 24, 2022

The FDA has signed off TScan Therapeutics Inc's (NASDAQ: TCRX) investigational new drug (IND) application for TSC-100 in hematologic malignancies patients...

Via Benzinga

12 Health Care Stocks Moving In Friday's Intraday Session ↗

October 15, 2021

Gainers Statera BioPharma (NASDAQ:STAB) shares rose 16.9% to $3.32 during Friday's regular session. The market value of their outstanding shares is at $91.7 million....

Via Benzinga

Stocks That Hit 52-Week Lows On Thursday ↗

May 05, 2022

During Thursday, 351 stocks hit new 52-week lows.

Via Benzinga

Stocks That Hit 52-Week Lows On Wednesday ↗

May 04, 2022

During Wednesday's trading, 435 companies set new 52-week lows.

Via Benzinga

Benzinga's Top Ratings Upgrades, Downgrades For December 16, 2021 ↗

December 16, 2021

Upgrades According to B of A Securities, the prior rating for Generac Holdings Inc (NYSE:

Via Benzinga

The Daily Biotech Pulse: Valneva Inks COVID-19 Vaccine Supply Contract In Europe, I-Mab Spikes On China Deal, DermTech Sinks On Guidance ↗

November 10, 2021

Here's a roundup of top developments in the biotech space over the last 24 hours. Stocks In Focus MorphoSys COO To Leave To Pursue Other Opportunities MorphoSys AG (NASDAQ:...

Via Benzinga

< Previous 1 2 3 4 5 6 7 Next >

Stock Quote API & Stock News API supplied by www.cloudquote.io. Quotes delayed at least 20 minutes. Market data may be delayed. Research information, not personalized advice.